Humanetics Corporation
At a glance
EmployeesNot reported
In business since1988
HeadquartersExcelsior, MN
SAM.gov UEIMSRQYLLQLYQ5
The company develops a drug called BIO 300, which is a radiation modulator intended to improve outcomes for cancer patients receiving radiation treatment for solid tumors, including non-small cell lung cancer, head and neck cancers, and prostate cancer. BIO 300 is also being studied for inflammatory lung diseases to limit inflammation and fibrosis, and for biodefense applications related to nuclear accidents and terrorism.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Humanetics Corporation | Excelsior | MN | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.

